3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Multiple Myeloma
38
Lymphoma, Non-Hodgkin
17
Lymphoma
8
Hodgkin Disease
8
Neoplasms, Plasma Cell
6
Leukemia, Lymphocytic, Chronic, B-Cell
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
3
Myelodysplastic Syndromes
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Sezary Syndrome
1
Recurrence
1
Paraproteinemias
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Lymphoproliferative Disorders
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Hairy Cell
1
Congenital Abnormalities
1
Burkitt Lymphoma
1
Blast Crisis
1
Interventions
Tacrolimus
4
Epoetin Alfa
4
Busulfan
4
fludarabine
3
Darbepoetin alfa
3
Bortezomib
3
fludarabine phosphate
2
dacetuzumab
2
Rituximab
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Lenalidomide
2
Early Intervention, Educational
2
Dexamethasone
2
Antilymphocyte Serum
2
Alemtuzumab
2
venetoclax
1
trametinib
1
ruxolitinib
1
plerixafor
1
isatuximab
1
ficlatuzumab
1
ferrous sulfate
1
ferric gluconate
1
ethanolamine oleate
1
dabrafenib
1
Vorinostat
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Trimethoprim
1
Tinzaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoproliferative Disorders
×
plerixafor
×
Plasma cell
×
Clear all
NCT01186224
2025-03-17
PHANTASTIC
University of Liverpool
Phase NA
Completed
60 enrolled